Doğan Bayram

14PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)HaematologyMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 16, 2026
Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancer.

|Dec 25, 2025
The Combined ALBI-FIB-4 Score for Prognostic Stratification in Hepatocellular Carcinoma: A Single Center Retrospective Study.

Doğan Bayram, Efe Cem Erdat, Sema Nur Özsan Çelebi

|Oct 29, 2025
Clinicopathologic Disease Characteristics and Their Association with Adjuvant Chemotherapy Outcomes in Pulmonary Large-Cell Carcinoma Patients with or Without Neuroendocrine Features.

Doğan Bayram, Oznur Bal, Efe Cem Erdat

|Oct 24, 2025
Comparison of the Efficacy of First-Line Pemetrexed-Platinum and Gemcitabine-Platinum Regimens in Malignant Peritoneal Mesothelioma.

Doğan Bayram, Safa Can Efil, Serap Türk

|Sep 27, 2025
The Impact of Clinical and Morphometric Parameters on Hematopoietic Engraftment Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Germ Cell Tumors.

Ömer Faruk Kuzu, Nuri Karadurmuş, Ahmet Gazi Acar

|Sep 03, 2025
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study.

Ogur Karhan, Serdar İleri, Zuhat Urakçı

Pageof 3

Frequent Collaborators

7 joint publications

Serhat Sekmek

5 joint publications

Öznur Bal

4 joint publications

Fahriye Tugba Kos

3 joint publications

Perihan Perkin